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Conventional open surgical repair, endovascular treatment
and hybrid technique constitute the three treatment
options for patients with type IV thoracoabdominal aneu-
rysms. Treatment is advocated to prevent rupture but
yields significant risk for spinal cord ischemia, cardiovas-
cular, renal and respiratory complications including death.
Refinements in open surgical techniques and branched
endovascular grafts repair together with the development
of hybrid techniques have been applied to the treatment of
type IV thoracoabdominal aneurysms to decrease the risk of
these complications. However, much of the evidence of the
argument is circumstantial. Large experiences are limited
to a few centers worldwide with inherent disparity between
patient groups and several limitations to the construction
of a prospective randomised trial. This controversial
subject is now open to discussion, and our debaters have
been given the challenge to clarify the evidence to justify
their preferred option for repair of type IV thor-
acoabdominal aneurysm.
doi: 10.1016/j.ejvs.2011.04.002* This paper is also being published in the Journal of Vascular
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I don’t believe there is necessarily a “best option” for type
IV thoracoabdominal aneurysms per se. What would be
optimal treatment for one patientmay not be the best option
for another. If the best option is based on the treatment
modality applied to the largest majority, then the answer
would depend on the institution and the patient population
served. However, I believe the best option is truly patient
specific and therefore the best treatment is really given by
the institution, which can offer all three treatment options
and select the patients most suitable for that intervention.Introduction
Thoracoabdominal aneurysms (TAAAs) tend to present in an
elderly population, often with extensive co-morbidity. They
are either identified incidentally or present late with
pressure symptoms as a consequence of size. Untreated,
despite the presence of co-morbidity, the mortality from
aneurysm rupture is high.1 It is in these very elderly
patients, with extensive co-morbidity, but large aneurysms
where there is no perfect treatment strategy that the least
invasive, cost-effective and readily applied technique is
therefore desirable.
Outside the excellent results from individual single
centre publications,2 population studies show that the
traditional approach to TAAA treatment shows room for* Tel.: þ44 203312 6666; fax: þ44 203312 2216.
E-mail address: michael.jenkins@imperial.nhs.uk.
Table 1 Absolute numbers of type IV aortic aneurysms
reported in visceral hybrid series.
Publication No. of type
IV cases
Total no. of cases
Quinones-Baldrich10 4 20
Lee7 7 17
Siegenthaler8 2 21
Drinkwater9 1 107
Donas6 13 58
Gawenda11 2 6
Biasi12 0 18
Fulton14 2 10
Chiesa13 2 13
2 M.P. Jenkinsimprovement with a 30 day elective mortality of 19% (40%
for those over 80 years) in the state of California.3 Whether
a less invasive technique or centralisation of patients to
higher volume centres (or both) is the answer is uncertain,
but my remit is to look at the various merits of the current
techniques available.
The visceral hybrid technique of extra-anatomical
debranching combined with aneurysm exclusion with
conventional covered aortic stent grafts was designed to
eliminate some of the known adverse aspects of conven-
tional open thoracoabdominal surgery to treat the most
extensive aneurysms.4,5 The absence of a thoracotomy was
seen as an advantage in patients with respiratory compro-
mise and the lack of aortic cross-clamping and consequent
re-perfusion injury allowed patients with reduced cardiac
reserve to remain haemodynamically stable. The combina-
tion of abdominal surgery and relatively little cardiac stress
has allowed the technique to be applied to unfit patients. It
is questionable whether this can be justified, but human
nature dictates that some patients with very large aneu-
rysms will want to consider any option available. This makes
comparison with other series in the literature difficult for
a number of reasons. Firstly, in general, most open surgical
series report a younger, fitter group of patients, and most
fenestrated/branched series, by definition, report
outcomes in patients anatomically suitable for endovascular
treatment. Secondly, the literature is somewhat contami-
nated by many small series very early in the learning curve
of the procedure and most series contain a variety of indi-
cations and extent of aneurysmal involvement.6 Many
authors are reporting the technique rather than a defined
group of patients to which it has been applied. Further-
more, the visceral hybrid technique has been taken up
widely and is now adopted by centres with little previous
experience of treating patients with TAAAs. Although it is
clearly desirable that as many patients as possible are at
least considered for treatment, I would question the wisdom
of a centre without extensive open surgical or fenestrated/
branched experience embarking on a treatment programme
as patients will not be given all the options available.
The visceral hybrid procedure has been used to treat
many types of aneurysms and I don’t doubt that it can be
used to treat type IV TAAAs (the first reported case was in
a patient with a type IV extent aneurysm4), but the ques-
tion here is whether it should? Without giving too much
away at the outset, I believe that except under certain
unusual circumstances, the answer is unequivocally, no.Evidence
Not all series classify the extent of aneurysmal involvement
and it is therefore difficult to make good outcome
comparisons. What is clear however, is that type IV TAAAs
make up a very small percentage of all aneurysms treated
by this technique (Table 1). Looking through the published
series that documented TAAA extent,6e14 only 12% of cases
involved treatment of type IV extent aneurysms. Within this
group of 270 cases, 107 were from one publication,9 which
described a single type IV extent case and that was
a patient whom had already underdone open type IV open
surgery and re-presented with a blow out of the proximalanastomosis. I believe this tells us that there are probably
better ways of repairing such aneurysms.
The majority of type IV TAAAs can be repaired via
a subcostal incision15 and therefore there is no advantage
of thoracotomy avoidance. Admittedly, there is potential
for haemodynamic instability and cardiac complications of
cross clamping at the level of the diaphragm, but with
careful optimization of ischaemic heart disease, such
problems can be reduced if not entirely eliminated. The
literature would seem to confirm this with contemporary
series >50 consecutive cases reporting very good elective
30-day mortality rates for open type IV surgery e 3%
Houston,2 6% Edinburgh16 and 3.5% St Mary’s.17 There is
ample evidence to show that open repair is durable in
survivors with very low rates of aneurysm-related compli-
cations in the long term.18 If we accept that such mortality
figures are difficult to improve on, we have to search for
an area where a different approach may confer some
advantages in terms of morbidity or recovery rate. Unfor-
tunately, I do not believe the visceral hybrid is of benefit
here either e a major laparotomy with extensive dissection
is necessary and if anything, a greater length of aortic
coverage is necessary to obtain a seal at the stent landing
zones, theoretically increasing the risk of spinal cord
ischaemia. This risk however is low for type IV extent
aneurysms and with a fenestrated/branched solution is
offset by the substantially less invasive approach afforded
by this technique as long as the internal iliac circulation is
preserved. However, paraplegia is not eliminated by
a totally endovascular approach e in Roselli’s series of 73
cases (62% type IV), the paralysis rate was nearly 3%.19
Indications for visceral hybrid in type IV TAAAs
So we must now ask ourselves if the complexity and
unproven durability of the visceral hybrid approach is ever
justified for type IV extent TAAAs. I would agree that if
a patient is relatively young and fit, conventional open
surgery is a proven strategy. If the anatomy is suitable and
the funds available, a fenestrated/branched approach is an
option if the elective nature of presentation allows time for
a bespoke device to be manufactured.
To play devil’s advocate, one could argue that if applied
to too many cases, the visceral hybrid procedure, if used
indiscriminately, could be said to be hampered by both the
Treatment of Type IV Thoracoabdominal Aneurysms 3early disadvantages of open surgery and the late ones of
the endovascular approach. However, as always, case
selection is the key and choosing the right procedure for an
individual patient paramount. For relatively unfit patients
with types IeIII aortic aneurysms and anatomy unsuitable,
or presentation too acute for a totally endovascular
approach, one can justify a visceral hybrid approach. I am
not convinced that this can be extrapolated to type IV
aneurysms for reasons outlined above, but there are certain
circumstances where this approach may have advantages:
- redo of previous open cases (false aneurysm, patch
blow out)
- extra-anatomical bypass to allow extension of
a previous infra/juxta-renal endovascular repair for
proximal neck dilatation
- significant visceral and renal artery stenosis combined
with a type IV TAAA
- patients with anatomy precluding a sub-costal
approach with concomitant respiratory compromise
- gross circumferential calcification at the potential
aortic clamp site
- as a temporary bridging procedure for symptomatic
mycotic aneurysms affecting the visceral segment.Conclusions
Publications from certain major US institutions would
suggest that the gold standard method of treatment for all
thoracoabdominal aneurysms is open surgery. I would agree
that this is a particularly good option for type IV aneurysms
in fit patients. There is consistent evidence in the literature
showing excellent results from higher volume institutions,
both within the US and Europe. However, such a conclusion
can only be applied to those patients afforded the oppor-
tunity of treatment in such institutions and population
studies prove that the majority of patients fair much less
well.
The reduction in invasiveness with a fenestrated/
branched approach is beyond question, but anatomical
constraints, manufacturing delays and financial consider-
ations continue to limit applicability. Despite the above, for
suitable patients and when funding allows, a totally endo-
vascular approach remains a desirable option.
Which leaves the visceral hybrid operation as very much
the third choice for type IV TAAAs. The advantages of this
approach can really only be gained when applied to more
extensive aneurysms and I do not think there is any justi-
fication for its routine use in uncomplicated type IV TAAAs.
There are special circumstances (as outlined above) where I
believe it is a good option and for such cases it remains
a very flexible and seemingly durable treatment.
To finally consider the debate again e there can be no
“best option” for all patients. I do not feel that “best
option” can be substituted for “only option” in units
without open thoracoabdominal surgical or fenestrated
endovascular experience. Although the visceral hybrid
technique has undoubtedly allowed patients to be treated
in local hospitals rather than be referred to larger speci-
alised units, it is questionable whether the results justify
this strategy. The key to successful outcomes in suchpatients is applying the best treatment to the most suitable
patient and as such, a unit should be able to offer all three
options. Certainly, there are cases where all three treat-
ment strategies could be used, but when weighed up
carefully, in the majority of cases, one will be seen as
superior. The debate therefore hinges on which treatment
is best for an individual patient rather than which is the
best treatment per se.References
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Part Two: Treatment of Type IV
Thoracoabdominal Aneurysms e
Fenestrated Stent-graft Repair is
Now the Best OptionS. Haulon a,*, R.K. Greenberg baVascular Surgery, Hoˆpital Cardiologique, CHRU de Lille,
Inserm U1008, Universite´ Lille 2, 59037 Lille Cedex, France
bCleveland Clinic Foundation, Cleveland, OH, USAIntroduction
The treatment of aneurysmal disease of the aorta has seen
profound changes in the past two decades since Parodi
et al.1 performed the first endovascular aneurysm repair. In
this period devices have evolved from simple covered
tubular stents to highly complex, custom-designed devices
incorporating branches and fenestrations which allow
treatment of complex aneurysms of the abdominal and
thoracic aorta. The utility of fenestrated devices for the
treatment of juxtarenal aneurysms is now well established
with several large series confirming satisfactory interme-
diate-term outcomes.2e4 When aneurysms involve the renal
and visceral vessels, the risks of open surgery increase, and
therefore, the potential benefit of an endovascular option
increases as well. The treatment of such aneurysms with
fenestrated devices began in 2002, and has become* Corresponding author. Tel.: þ33 320 445 005.
E-mail address: stephan.haulon@chru-lille.fr (S. Haulon).increasingly more popular as the implantation technique
and device design has evolved. Publications addressing the
outcome of endovascular repair of thoracoabdominal
aneurysms (TAAA) have been quite favourable compared
with the results published for open surgery.5e10 The endo-
vascular procedure has been relegated to larger volume
centres of excellence, much like most open TAAA repair.
However, much of the published literature on endovascular
treatment of TAAAs has reported outcomes for the
conglomerate group of all types of TAAA, without specifi-
cally focussing upon any given subtype of TAAA. This has
resulted in considerable heterogeneity with respect to
reported outcomes and conclusions. This report focuses on
the outcomes and assessment of the results when the
analysis is limited to type IV TAAA.11Methods
We did a retrospective review of two prospective databases
including all patients undergoing endovascular repair of
abdominal aortic, thoracoabdominal and thoracic aneu-
rysms at the Centre Hospitalier Regional Universitaire de
Lille, Lille, France and the Cleveland Clinic, Ohio, United
States. From this database we selected the patients who
had repair of type IV TAAA using fenestrated or branched
endovascular devices. All patients treated were considered
high-risk for open repair of their aneurysm as described in
previous publication.5 In an effort to define the extent of
the design and plan the intended repair, anatomic images
were reconstructed on a 3D imaging workstation (Aquarius
WS, Terarecon Inc, Mateo, California, USA) and centreline
of flow reconstructions were used to design a customised
endoprosthesis. The design process and implantation
technique have been described in detail previously and are
beyond the scope of this article.10,14 For the purposes of
this article we defined a type IV TAAA as being any aneu-
rysm that required a branch (side-arm or reinforced
fenestration) for the superior mesenteric artery (SMA) and
at least one of the renal arteries, with a proximal sealing
zone above the visceral segment, akin to type IV TAAA as
defined by the Crawford classification.15 Follow-up clinical
assessment, laboratory testing (including eGFR evaluation),
CTA, duplex ultrasonography, and plain chest and abdom-
inal radiographs were performed at prior to discharge or
within 1 month of follow-up, then annually thereafter.
Additional follow-up studies were obtained at 6 and 18
months in selected patients.
Statistics: Means are expressed with the SD.
KaplaneMeier life-table analysis techniques were used to
estimate survival during follow-up.Results
Between January 2004 and March 2010 231 patients with
type IV TAAA were treated with an endoprosthesis. Patient
characteristics are shown in Table 1. All devices were
successfully deployed as planned. There were no acute or
late conversions to open surgical repair.
